Search research articles
Contact Us
Filters
Showing results (181-190 of 194) with videos related to
Page
of 20
Sort By:
MMWR. Morbidity and Mortality Weekly Report
|
January 27, 2022
Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021
Mark W Tenforde, Manish M Patel, Manjusha Gaglani, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 23, 2022
Vaccine Effectiveness of Primary Series and Booster Doses against Omicron Variant COVID-19-Associated Hospitalization in the United States
Katherine Adams, Jillian P Rhoads, Diya Surie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 8, 2022
Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States
Nathaniel M Lewis, Wesley H Self, Manjusha Gaglani, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 16, 2021
Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States
Mark W Tenforde, Manish M Patel, Adit A Ginde, et al.
Open Forum Infectious Diseases
|
January 25, 2023
Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022
Nathaniel M Lewis, Nancy Murray, Katherine Adams, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 17, 2022
Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States
Mark W Tenforde, Wesley H Self, Yuwei Zhu, et al.
JAMA
|
November 4, 2021
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity
Mark W Tenforde, Wesley H Self, Katherine Adams, et al.
The Journal of Infectious Diseases
|
December 21, 2021
Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021
Nathaniel M Lewis, Eric A Naioti, Wesley H Self, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 16, 2022
Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: A Prospective Observational Study
Adam S Lauring, Mark W Tenforde, James D Chappell, et al.
BMJ (Clinical Research Ed.)
|
March 10, 2022
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study
Adam S Lauring, Mark W Tenforde, James D Chappell, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 194) with videos related to
Sort By:
Page
of 20
MMWR. Morbidity and Mortality Weekly Report
|
January 27, 2022
Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021
Mark W Tenforde, Manish M Patel, Manjusha Gaglani, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 23, 2022
Vaccine Effectiveness of Primary Series and Booster Doses against Omicron Variant COVID-19-Associated Hospitalization in the United States
Katherine Adams, Jillian P Rhoads, Diya Surie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 8, 2022
Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States
Nathaniel M Lewis, Wesley H Self, Manjusha Gaglani, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 16, 2021
Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States
Mark W Tenforde, Manish M Patel, Adit A Ginde, et al.
Open Forum Infectious Diseases
|
January 25, 2023
Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022
Nathaniel M Lewis, Nancy Murray, Katherine Adams, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 17, 2022
Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States
Mark W Tenforde, Wesley H Self, Yuwei Zhu, et al.
JAMA
|
November 4, 2021
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity
Mark W Tenforde, Wesley H Self, Katherine Adams, et al.
The Journal of Infectious Diseases
|
December 21, 2021
Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021
Nathaniel M Lewis, Eric A Naioti, Wesley H Self, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 16, 2022
Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: A Prospective Observational Study
Adam S Lauring, Mark W Tenforde, James D Chappell, et al.
BMJ (Clinical Research Ed.)
|
March 10, 2022
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study
Adam S Lauring, Mark W Tenforde, James D Chappell, et al.
Page
of 20